‌

US Patent 11041153 P-ethoxy nucleic acids for STAT3 inhibition

Patent 11041153 was granted and assigned to Bio-Path Holdings on June, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Bio-Path Holdings

0

Current Assignee

Bio-Path Holdings

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Ana Tari Ashizawa0

Date of Patent

June 22, 2021

0

Patent Application Number

166064190

Date Filed

April 19, 2018

0

Patent Citations

US Patent 10335428 P-ethoxy nucleic acids for liposomal formulation

Patent Citations Received

US Patent 12012601 Combination therapy with liposomal antisense oligonucleotides

0

Patent Primary Examiner

Ekaterina Poliakova-Georgantas

0

Patent abstract

Provided herein are improved delivery systems for oligonucleotides, said delivery system comprising a liposome that comprises neutral phospholipids and a P-ethoxy oligonucleotide, which targets a STAT3-encoding polynucleotide. Methods of treating patients with said delivery systems are also provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11041153 P-ethoxy nucleic acids for STAT3 inhibition

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.